Your Questions. Answered with Confidence.

Yes, Condranol is owned by Novanto, a U.S. based manufacturer. It’s facilities are FDA-registered and regularly inspected. Because Condranol is not manufactured by a third party, it is more consistently available to veterinarians and their customers. 

Condranol is a medical device. A medical device achieves a therapeutic effect by mimicking the physical properties
of synovial fluid. This mechanical lubrication and cushioning provided by Condranol helps protect the joint in a non-chemical/non-metabolic manner.

No. Condranol is an original formulation, carefully researched, tested and manufactured to ultimately achieve the therapeutic effect demanded by leading equine veterinarians. 

No, Condranol is exclusively distributed through veterinarians. Condranol and Novanto are firmly committed to the bond between reputable veterinarians, patients and their owners. 

Condranol is the only product that provides equine veterinarians with a sterile, pharmaceutical-grade
joint lavage that is safer for at-risk horses and minimally reactive due to single-molecule purity.